These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16144325)

  • 21. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein instability in poly(lactic-co-glycolic acid) microparticles.
    van de Weert M; Hennink WE; Jiskoot W
    Pharm Res; 2000 Oct; 17(10):1159-67. PubMed ID: 11145219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of microclimate pH in poly(lactic-co-glycolic acid) films.
    Ding AG; Shenderova A; Schwendeman SP
    J Am Chem Soc; 2006 Apr; 128(16):5384-90. PubMed ID: 16620110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors.
    Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ
    Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of additives on the release profile of nifedipine from poly(DL-lactide-co-glycolide) microspheres.
    Sansdrap P; Moës AJ
    J Microencapsul; 1998; 15(5):545-53. PubMed ID: 9743911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance.
    Grayson AC; Cima MJ; Langer R
    Biomaterials; 2005 May; 26(14):2137-45. PubMed ID: 15576189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arterial uptake of biodegradable nanoparticles: effect of surface modifications.
    Labhasetwar V; Song C; Humphrey W; Shebuski R; Levy RJ
    J Pharm Sci; 1998 Oct; 87(10):1229-34. PubMed ID: 9758682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
    Clark A; Milbrandt TA; Hilt JZ; Puleo DA
    Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
    Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
    Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hot Melt Extrusion for Sustained Protein Release: Matrix Erosion and In Vitro Release of PLGA-Based Implants.
    Cossé A; König C; Lamprecht A; Wagner KG
    AAPS PharmSciTech; 2017 Jan; 18(1):15-26. PubMed ID: 27193002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
    Crotts G; Park TG
    J Microencapsul; 1998; 15(6):699-713. PubMed ID: 9818948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving release completeness from PLGA-based implants for the acid-labile model protein ovalbumin.
    Duque L; Körber M; Bodmeier R
    Int J Pharm; 2018 Mar; 538(1-2):139-146. PubMed ID: 29355654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation.
    Wu XS; Wang N
    J Biomater Sci Polym Ed; 2001; 12(1):21-34. PubMed ID: 11334187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of monomer order on the hydrolysis of biodegradable poly(lactic-co-glycolic acid) repeating sequence copolymers.
    Li J; Rothstein SN; Little SR; Edenborn HM; Meyer TY
    J Am Chem Soc; 2012 Oct; 134(39):16352-9. PubMed ID: 22950719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro evaluation of the effects of various additives and polymers on nerve growth factor microspheres.
    Sun H; Xu F; Guo D; Liu G
    Drug Dev Ind Pharm; 2014 Apr; 40(4):452-7. PubMed ID: 23565585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug release from irradiated PLGA and PLLA multi-layered films.
    Loo SC; Tan ZY; Chow YJ; Lin SL
    J Pharm Sci; 2010 Jul; 99(7):3060-71. PubMed ID: 20112427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential avoidance of adverse analgesic effects using a biologically "smart" hydrogel capable of controlled bupivacaine release.
    Taraballi F; Minardi S; Corradetti B; Yazdi IK; Balliano MA; Van Eps JL; Allegri M; Tasciotti E
    J Pharm Sci; 2014 Nov; 103(11):3724-3732. PubMed ID: 25266282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S; Tros de Ilarduya C
    Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extended pulsated drug release from PLGA-based minirods.
    Danyuo Y; E Oberaifo O; Obayemi JD; Dozie-Nwachukwu S; J Ani C; Odusanya OS; Zebaze Kana MG; Malatesta K; Soboyejo WO
    J Mater Sci Mater Med; 2017 Apr; 28(4):61. PubMed ID: 28251469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of polymeric nanoparticles and its applications as drug delivery systems for acne treatment.
    Reis CP; Martinho N; Rosado C; Fernandes AS; Roberto A
    Drug Dev Ind Pharm; 2014 Mar; 40(3):409-17. PubMed ID: 23480566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.